cyclohexanol has been researched along with Nerve Degeneration in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dikshit, M; Shukla, S; Singh, KP; Singh, M | 1 |
| Amenta, PS; Elliott, MB; Jallo, JI; Tuma, RF | 1 |
| Ahmed, Z; Baker, D; Croxford, JL; Cuzner, ML; Giovannoni, G; Hankey, DJ; Jackson, SJ; Ledent, C; Petzold, A; Pocock, JM; Pryce, G; Thompson, AJ | 1 |
| Bonner, TI; Herkenham, M; Howlett, AC; Matsuda, LA; Westlake, TM | 1 |
| Sañudo-Peña, MC; Walker, JM | 1 |
5 other study(ies) available for cyclohexanol and Nerve Degeneration
| Article | Year |
|---|---|
Assessment of in-utero venlafaxine induced, ROS-mediated, apoptotic neurodegeneration in fetal neocortex and neurobehavioral sequelae in rat offspring.
Topics: Animals; Animals, Newborn; Antidepressive Agents, Second-Generation; Apoptosis; bcl-2-Associated X Protein; Cyclohexanols; Disease Models, Animal; Dose-Response Relationship, Drug; Embryo, Mammalian; Exploratory Behavior; Female; Male; Microscopy, Electron; Neocortex; Nerve Degeneration; Pregnancy; Proto-Oncogene Proteins c-bcl-2; Pyelectasis; Rats; Reactive Oxygen Species; Venlafaxine Hydrochloride | 2015 |
A cannabinoid type 2 receptor agonist attenuates blood-brain barrier damage and neurodegeneration in a murine model of traumatic brain injury.
Topics: Animals; Anisoles; Blood-Brain Barrier; Brain Injuries; Cyclohexanols; Drug Evaluation, Preclinical; Exploratory Behavior; Macrophages; Male; Mice; Mice, Inbred C57BL; Microglia; Nerve Degeneration; Neurons; Neuroprotective Agents; Receptor, Cannabinoid, CB2; Rotarod Performance Test; Wounds, Nonpenetrating | 2012 |
Cannabinoids inhibit neurodegeneration in models of multiple sclerosis.
Topics: Animals; Aspartic Acid; Axons; Benzoxazines; Cannabinoids; Cyclohexanols; Dizocilpine Maleate; Encephalomyelitis, Autoimmune, Experimental; Excitatory Amino Acid Agonists; Gene Deletion; Humans; Mice; Mice, Transgenic; Monomeric GTP-Binding Proteins; Morpholines; Multiple Sclerosis; N-Methylaspartate; Naphthalenes; Nerve Degeneration; Nuclear Proteins; Receptors, Cannabinoid; Receptors, Drug; Receptors, N-Methyl-D-Aspartate; Retina; Saccharomyces cerevisiae Proteins; Spinal Cord; Uveitis | 2003 |
Cannabinoid receptor binding and messenger RNA expression in human brain: an in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer's brains.
Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Autoradiography; Brain Chemistry; Cannabinoids; Cyclohexanols; Female; Hippocampus; Humans; Image Processing, Computer-Assisted; In Situ Hybridization; Male; Memory; Middle Aged; Nerve Degeneration; Receptors, Cannabinoid; Receptors, Drug; RNA Probes; RNA, Messenger; Silver Staining | 1994 |
A novel neurotransmitter system involved in the control of motor behavior by the basal ganglia.
Topics: Action Potentials; Analgesics; Animals; Basal Ganglia; Benzoxazines; Bicuculline; Cannabinoids; Cyclohexanols; Dopamine; Dopamine Agonists; Electrophysiology; GABA Antagonists; gamma-Aminobutyric Acid; Morpholines; Motor Neurons; Naphthalenes; Nerve Degeneration; Neurotransmitter Agents; Oxidopamine; Piperidines; Pyrazoles; Quinpirole; Rats; Rimonabant; Sympatholytics; Thalamic Nuclei | 1998 |